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Abstract Autism is a neurodevelopmental disorder that
manifests in childhood as social behavioral abnormalities,
such as abnormal social interaction, impaired communication,
and restricted interest or behavior. Of the known causes of
autism, duplication of human chromosome 15q11–q13 is the
most frequently associated cytogenetic abnormality. Chromo-
some 15q11–q13 is also known to include imprinting genes.
In terms of neuroscience, it contains interesting genes such as
Necdin, Ube3a, and a cluster of GABAA subunits as well as
huge clusters of non-coding RNAs (small nucleolar RNAs,
snoRNAs). Phenotypic analyses of mice genetically or
chromosomally engineered for each gene or their clusters
on a region of mouse chromosome seven syntenic to human
15q11–q13 indicate that this region may be involved in
social behavior, serotonin metabolism, and weight control.
Further studies using these models will provide important
clues to the pathophysiology of autism. This review over-
views phenotypes of mouse models of genes in 15q11–q13
and their relationships to autism.
Keywords 15q11–q13 .Mouse model . Autism .
Chromosome . CNV. Serotonin . Epigenetics
Autism
Autism is a developmental brain disorder whose definition has
been extended to autism spectrum disorders (ASDs), including
non-pervasive development disorder and Asperger syndrome
(Levitt and Campbell 2009). The prevalence of autism is
increasing and currently stands at one in every 150
individuals. Its influence on modern society is increasing,
especially in developed countries, where birthrates are low
and the management of children with these disorders is a
serious social issue. However, the cause of autism and its
pathophysiology remain unknown and require further
research from a number of different approaches. Among the
neuropsychiatric diseases, autism is considered as an appro-
priate disorder that can be approached from biological aspects.
This is partly because genetic studies show that the concor-
dance rate of autism in identical twins is over 90%, which is
higher than other neuropsychiatric diseases such as schizo-
phrenia and mood disorders (Abrahams and Geschwind
2008).
Most autism cases are sporadic and their causes are still
unknown; however, 10–20% have known causes, such as
(1) comorbidity with other diseases, such as fragile X
syndrome, tuberous sclerosis, and Rett syndrome; (2)
genome abnormalities, including copy number variations
(CNVs), such as 15q11–q13 and 16q11.2; and (3) single
gene mutations such as NLGN3/4, NRXN1, and SHANK2/3
(Abrahams and Geschwind 2008; Berkel et al. 2010; Cook
and Scherer 2008; Kumar et al. 2008; Marshall et al. 2008;
Pinto et al. 2010; Toro et al. 2010; Vorstman et al. 2006;
Weiss et al. 2008). Recent genetic screening using cutting-
edge technologies has revealed more CNV cases than
previously expected (Cook and Scherer 2008). Given the
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rapid progress in current technologies, such as array
comparative genomic hybridization (array CGH) and next
generation sequencers, and their availability for clinical use,
it is likely that more CNV cases will be diagnosed in the
near future.
CNVs are important not only in explaining human
heterogeneity but also because they are responsible for
several diseases, especially neuropsychiatric disorders
including autism. Human chromosome 15q11–q13 is the
second most frequent region to contain chromosome
abnormalities, probably because it contains large repeat
sequences. Depending on its copy variant, this region
causes different diseases, such as Prader–Willi syndrome
(PWS), Angelmann syndrome (AS), and autism, all sharing
ASD features. Comparison of mouse models of 15q copy
variants with phenotypes of genetically engineered mice of
each gene, with or without imprinting, will provide some
clues to the pathophysiology of autism.
Mouse chromosome seven is syntenic to human
chromosome 15q11–q13
Chromosomal abnormalities were known as causes of
autism before the era of current genome technology. Among
them, human 15q11–q13 is the most notable chromosome
region (Vorstman et al. 2006) (Fig. 1). This region is also
known to be an imprinting region (Chamberlain and
Lalande 2010a, b; Nicholls and Knepper 2001). Thus, there
are three classified regions: paternally, maternally, and
biallelically expressed regions. Human chromosome
15q11–q13 is conserved in mouse chromosome seven and
it is believed that the imprinting status is conserved
between mouse and human (Yang et al. 1998). Knockout
(KO) mice for each gene corresponding to a human
counterpart have been generated and studied (Table 1).
Paternally expressed genes
In the paternally expressed regions of the mouse chromo-
some, Mkrn3, Magel2, Necdin (Ndn), Snrpn-Snurf, and
huge clusters of small nucleolar RNAs (snoRNAs) are
present. Magel2 is involved in hypothalamic functions, and
its deficient mice show abnormal circadian rhythm, body
weight, and hormonal secretion, such as testosterone
(Bischof et al. 2007; Kozlov et al. 2007; Mercer and
Wevrick 2009). Ndn was first identified as a gene related to
neural differentiation (Maruyama et al. 1991). Ndn KO
mice were generated from multiple laboratories; however,
they display different phenotypes, from no abnormality to
respiratory distress and lethality, similar to PWS, depending
on the strain of mouse (Gerard et al. 1999; Kuwako et al.
2005; Muscatelli et al. 2000; Tsai et al. 1999a). Muscatelli
et al. observed a neonatal lethality of variable penetrance in
Ndn mutants, and they showed a reduction in both
oxytocin-producing and luteinizing hormone-releasing hor-
mone (LHRH)-producing neurons in the hypothalamus and
emotional and cognitive-related behaviors reminiscent of
PWS (Muscatelli et al. 2000). Interestingly, oxytocin is
known to be related to social behavior and is expected to be
a candidate for therapeutics of ASD (Insel 2010). Ndn
deficiency induces perinatal serotonergic alterations that
affect the maturation and function of the respiratory
network, inducing respiratory problems (Zanella et al.
2008). Serotonergic and catecholaminergic projections are
reduced in the Ndn null embryo (Lee et al. 2005). Provided
that serotonin is involved in symptoms of autism, Ndn is a
candidate for further studies to reveal its involvement in
abnormal social behavior. Additionally, from studies using
Ndn KO mice, it is reported that Ndn is involved not only in
TrkA signaling (Kuwako et al. 2005) but also promotes
tangential migration of neocortical interneurons from the
basal forebrain (Kuwajima et al. 2010). The fact that the
neocortical interneurons are important for development of
inhibitory neural circuits also makes Ndn a possible
candidate for causing an imbalance of the excitatory/
inhibitory ratio. Thus, although it is still controversial
whether Ndn is a cause of PWS, it is an intriguing target
gene for further analyses in terms of developmental brain
disorders, including ASDs. Snrpn is a small nuclear
ribonucleoprotein N and the Snrpn promoter is located in
a maternally methylated CpG island within an imprinting
center (IC). Mutations of Snrpn are not sufficient to induce
PWS in mice, but a larger deletion including the PWS-IC
and Ndn show phenotypes common to PWS infants (Yang
et al. 1998). Paternal transmission of IC deletions results in
a PWS-like phenotype in mice (Bielinska et al. 2000). The
Fig. 1 Genes on human chromosome 15q11–q13. Clusters of non-coding RNA, such as HBII-52 and HBII-85, are omitted. The original data are
taken from UCSC Genome Browser (http://genome.ucsc.edu)
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Table 1 Genes on human chromosome 15q11–q13 and the phenotypes of their genetically engineered mice
Locus Line Phenotypes Reference
Mkrn3 KO No obvious phenotypes Jong et al. 1999
Magel2 Targeted reporter
(LacZ insertion)
Neonatal growth retardation, excessive weight
gain, and increased adiposity after weaning
Bischof et al. 2007
Targeted reporter
(LacZ insertion)
Altered circadian rhythms, hypophagia,
reduced orexin neurons in the
lateral hypothalamus
Kozlov et al. 2007
Targeted reporter
(LacZ insertion)
Extended and irregular estrous cycle,
decreased testosterone, reduced olfactory
preference for female odors
Mercer and Wevrick 2009
Conventional KO Neonatal lethality due to impaired suckling Schaller et al. 2010
Ndn Conventional KO Early postnatal lethality due to
respiratory defect
Gerard et al. 1999
Targeted reporter
(LacZ insertion)
No obvious phenotypes Tsai et al. 1999a
Conventional KO Postnatal lethality, reduced oxytocin producing
and luteinizing hormone releasing hormone
producing neuron, skin scraping, increased
spatial learning
Muscatelli et al. 2000
Conventional KO Reduced substance P containing neuron,
high tolerance to thermal pain
Kuwako et al. 2005
Conventional KO Central respiratory deficits, altered serotonergic
metabolism, enlargement of 5-HT vesicles
Zanella et al. 2008
Conventional KO Impaired tangential migration of
cortical interneuron
Kuwajima et al. 2010
PWS-IC Conventional KO Died shortly after birth, small Yang et al. 1998
Conventional KO Imprinting defect Bielinska et al. 2000
Gene targeting
(SNRPN human exon 1 switch)
Paternal transmission postnatal lethality
(not fully penetrant), growth deficiency.
Loss of Ndn, Magel2, and Mkrn3 expression
Johnstone et al. 2006
Snurf Conventional KO No obvious phenotype Tsai et al. 1999b
Snrpn Conventional KO No obvious phenotype Yang et al. 1998
Conventional KO (Ex1=0.9 kb) No obvious phenotype Bressler et al. 2001
Conventional KO
(Ex1=4.8 kb) PWS-IC+/−
40–50% lethality (strain dependency) Bressler et al. 2001
MBII-85/
Snord116
Chromosome engineering
(Cre lox deletion)
Early onset postnatal growth deficiency,
defect of motor learning, increased
anxiety, hyperphagia
Ding et al. 2008
Chromosome engineering
(Cre lox deletion)
Postnatal lethality (strain dependency),
growth retardation
Skryabin et al. 2007
MBII-52/
Snord115
Radiation induced mutant
(large deletion) p30pUb
Paternal transmission: loss of MbII-52/Snord115
and Ube3a expression. No obvious phenotype
Ding et al. 2005
Conventional KO
(Ex1=4.8 kb) PWS-IC+/−
Increased in editing of 5htr2c, impulsive
responding, less locomotor activity, reactivity
to palatable foodstuffs
Doe et al. 2009
Snurf-Snrpn to
Ube3a deletion
Chromosome engineering
(Cre-loxP deletion)
Partial postnatal lethality, growth deficiency Tsai et al. 1999b
Ube3a Conventional KO
(maternal transmission)
Maternal transmission: reduced brain weight,
impaired motor function, inducible seizures,
deficit in context-dependent fear conditioning,
abnormal hippocampal electroencephalographic
recordings and severely impaired long-term
potentiation
Jiang et al. 1998
Targeted reporter (maternal
transmission LacZ insertion)
Maternal transmission: reduced brain weight,
impaired motor function, impaired spatial
learning, deficit in context-dependent fear
conditioning, abnormal hippocampal
electroencephalographic recordings
Miura et al. 2002
Targeted reporter (maternal
transmission LacZ insertion)
Sleep disturbance Colas et al. 2005
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Table 1 (continued)
Locus Line Phenotypes Reference
Conventional KO
(maternal transmission)/
CamKII-T305V/T306A
double mutant
Rescued various abnormalities in
Ube3a−/+ mutant; reduced seizure,
improved motor coordination and
spatial learning
van Woerden et al. 2007
YFP fused to Ube3a Visualized ube3a protein, Ube3a is
imprinted in all regions of the brain
Dindot et al. 2008
Conventional KO
(maternal transmission)
Altered licking behavior, defects in rope
climbing, grip strength, gait, and a raised
beam task
Heck et al. 2008
Conventional KO
(maternal transmission)
Impaired experience dependent maturation
of excitatory cortical circuits, deficits in
ocular dominance plasticity
Yashiro et al. 2009
Conventional KO
(maternal transmission)
Lack of rapid and mature ocular
dominance plasticity
Sato and Stryker 2010
Atp10a Radiation induced
chromosomal deletion p30PUb
(Ube3a to Gabrb3 deletion)
Maternal deletion showed greater body weight,
adiposity index, plasma insulin, leptin,
triglyceride concentration
Dhar et al. 2004
Ube3a-Gabrb3 1.6 Mb deletion (Ube3a to Gabrb3)
chromosome engineering
Similar to the phenotypes of Ube3a and Gabrb3
KO mice, increased USVs
Jiang et al. 2010
Gabrb3 Conventional KO mouse 90% KO mice display neonate (−24 h) lethal,
60% cleft palate, some mice are viable that
showed hyperactive, higher sensitivity to
sensory stimuli, motor difficulties, myoclonus,
epileptic seizures
Homanics et al. 1997
Conventional KO mouse Electroencephalographic abnormality,
seizures, deficits in learning and memory,
poor motor skills
DeLorey et al. 1998
Conventional KO mouse 44% decreased norepinephrine in spinal cord Ugarte et al. 2001
Conventional KO mouse Lower REM sleep time, greater EEG delta power Wisor et al. 2002
Point mutation KI mouse
(N265M; second
transmembrane region)
Abolished suppression of noxious-evoked
movements in response to the intravenous
anesthetics
Jurd et al. 2003
Conventional KO mouse Enlarged pericoerulear dendritic zone of the
locus coeruleus, hypotonia, less marble
burying behavior
Hashemi et al. 2007
Conventional KO mouse Deficits in activities related to social behavior,
altered exploratory behavior, hypoplasia
of the cerebellar vermis
DeLorey et al. 2008
Conditional KO
(CamKII or Synapsin I Cre)
Synapsin I=>60% died in neonate,
CamKII=>30% died in 15–25 days of age,
hyperactive, sensitive for etomidate
Ferguson et al. 2007
Gabra5 Conventional KO mouse Enhanced spatial learning, decreased amplitude
of IPSC, and enhanced amplitude of
paired-pulse facilitation of fEPSP in CA1
of hippocampus
Collinson et al. 2002
Conventional KO mouse Normal behavioral phenotype for
fear-associated contextual learning
Cheng et al. 2006
Conventional KO mouse Reduced threshold for the induction of LTP Martin et al. 2010
Point mutation KI mouse
(H105R; diazepam insensitive)
Impaired the activity of diazepam, reduction
of Gabra5 protein level, facilitated trace
fear conditioning
Crestani et al. 2002
Point mutation KI mouse (H105R) Attenuated prepulse inhibition, increased
spontaneous locomotor activity
Hauser et al. 2005
Gabrg3 No No No
Oca2 Spontaneous, ENU induced,
radiation induced mutant mouse
Hypopigmentation, melanosomal defect Gardner et al. 1992
Johnson et al. 1995
Herc2 Spontaneous, ENU induced,
radiation induced mutant mouse
(many mutants)
Sterility, defects in growth, coordination,
fertility, maternal behavior. Jerky gait
Lehman et al. 1998
Walkowicz et al. 1999
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human PWS-IC could acquire a methylation imprint in
mouse oocytes but the imprint is lost in somatic cells,
suggesting that the human imprinting center demonstrates
conserved acquisition, but diverged maintenance, of im-
printing in a mouse model for AS imprinting defects
(Johnstone et al. 2006). The main promoter of Snrpn is
not required for the function of the PWS-IC, and the 4.8-kb
deletion induces a severe phenotypic effect and a partial
imprinting defect; however, this defect is less severe than
that with the 42-kb deletion of the PWS-IC (Bressler et al.
2001; Yang et al. 1998). Paternal deletion from Snrpn to
Ube3a in the mouse causes hypotonia, growth retardation,
and partial lethality (Tsai et al. 1999b). The non-coding
RNA region includes HBII-52 and HBII-85. Knockout mice
of MBII-85, a mouse homolog of HBII-85, show growth
retardation, increased anxiety, and hyperphagia (Ding et al.
2008; Skryabin et al. 2007). Recently, HBII-85 was
reported as a cause of PWS (Duker et al. 2010; Sahoo et
al. 2008). On the other hand, knockout mice of MBII-52, a
mouse homolog of HBII-52, display increased RNA editing
of the serotonin 2c receptor (5-HT2cR) and less locomotor
activity (Doe et al. 2009). In terms of the relationship
between serotonin and autism, MBII52 is an interesting
candidate gene.
Maternally expressed genes
Maternally expressed genes in chromosome 15q11–q13
include Ube3a and Atp10a. Ube3a is an E3 ubiqutin ligase
and is known to be a causative gene for AS (Kishino et al.
1997; Matsuura et al. 1997). Ube3a knockout mice show
impaired motor function, inducible seizures, learning
deficits (Jiang et al. 1998; Miura et al. 2002), and sleep
disturbance (Colas et al. 2005). The ataxic and long
potentiation phenotypes are rescued by reduction of
αCaMKII inhibitory phosphorylation (van Woerden et al.
2007). Knock-in (KI) Ube3a-YFP fusion reporter mice
show that Ube3a is imprinted in all regions of the brain, but
is biallelically expressed in glial cells (Dindot et al. 2008).
Maternally Ube3a-deficient mice show altered linking
behavior, which has been associated with cerebellar control
(Heck et al. 2008). Recently, Ube3a was extensively
characterized in neurons and found to be involved in
synaptic plasticity (Greer et al. 2010; Margolis et al. 2010;
Sato and Stryker 2010; Yashiro et al. 2009). A genetic study
also reported the involvement of Ube3a in ASD (Glessner
et al. 2009). Ube3a is the primary candidate gene for
causing the phenotypic features in duplication 15q autism.
In contrast, Atp10a, an aminophospholipid translocase, has
been less comprehensively studied than Ube3a, and its
imprinting status remains unclear (DuBose et al. 2010;
Kayashima et al. 2003). Mice with a radiation-induced
maternal deletion, including Ube3a and Gabrb3, are a
model of obesity and type two diabetes (Dhar et al. 2004).
Mice with a large maternal deletion from Ube3a to Gabrb3,
produced by chromosome engineering, show altered ultra-
sonic vocalization, impaired learning and memory, and
display parent of origin effects (Jiang et al. 2010).
Non-imprinting genes
In the conventional biallelic region, there is a cluster of
GABAA receptor subunits (Gabrb3, Gabra5, Gabrg3),
Oca2, and Herc2. The GABAA receptor is one of the
major neurotransmitter receptors and forms the most
notable target in this region because an imbalance between
excitatory and inhibitory neurons during development is a
pathophysiological hypothesis of developmental brain disor-
ders, including ASD (Rubenstein and Merzenich 2003). Of
the GABAA receptor subunits, the GABAA β3 subunit
(encoded by the Gabrb3 gene) is well studied. Its deficient
mice show epileptic seizures, deficits in learning and
memory, poor motor skills (DeLorey et al. 1998; Homanics
et al. 1997), as well as sleep disturbance, such as lower REM
sleep time and greater EEG delta power than the wild-type
(WT) (Wisor et al. 2002). The level of norepinephrine in the
spinal cord of Gabrb3 KO mice was less than that of WT
mice, suggesting that β3 subunit-containing GABAA recep-
tors mediate the trophic effects on a subpopulation of
spinally projecting noradrenergic neurons (Ugarte et al.
2001). Furthermore, Gabrb3 N265M KI mice display altered
general anesthetic actions (Jurd et al. 2003). Gabrb3 KO
mice show expansion of the plexus of locus coeruleus
dendrites, with a concurrent reduction in muscle tone and
marble burying behavior (Hashemi et al. 2007). They also
exhibit hypoplasia of cerebellar vermal lobules and impaired
social and exploratory behaviors in addition to deficits in
non-selective attention (DeLorey et al. 2008). Survivors of
pan-neuronal Gabrb3 knockouts are overtly normal, whereas
those of forebrain selective knockouts have reduced fertility,
are hyperactive, and some become obese (Ferguson et al.
2007). An association between a specific GABAA β3
receptor defect and autism has been reported recently
(Delahanty et al. 2010). Thus, Gabrb3 is also an intriguing
candidate gene in the region with respect to autism. Gabra5
KO mice display enhanced spatial learning, decreased
amplitude of inhibitory post-synaptic current (IPSC), and
enhanced amplitude of paired-pulse facilitation of excitatory
postsynaptic potential (EPSP) (Collinson et al. 2002). While
Gabra5 KO mice exhibit a normal behavioral phenotype for
fear-associated contextual learning (Cheng et al. 2006) and
no differences in long-term potentiation (LTP) in hippocampal
slices (Collinson et al. 2002), they show reduced threshold
for the induction of LTP via mechanisms that are indepen-
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dent of synaptic inhibition (Martin et al. 2010). On the other
hand, α5 (H105R) KI mice, in which a partial reduction of
α5 GABAA receptor restricted to CA1-3 subfield of the
hippocampus was achieved, exhibit facilitated trace fear
conditioning (Crestani et al. 2002). Moreover, H105R mutant
mice show attenuated prepulse inhibition (PPI) and increased
spontaneous locomotor activity (Hauser et al. 2005). Herc2
contains a COOH-terminal HECT domain and functions as
an assembly factor for the complex of an E3 ubiquitin ligase
(Bekker-Jensen et al. 2010). Mutant mice of Herc2 show
defects in growth (Lehman et al. 1998), but the physiological
functions of Herc2 in the brain remain unknown.
Genes between BP1 and BP2
In addition to genes between breakpoints BP2 and BP3,
there are four highly homologous genes (Nipa1, Nipa2,
Cyfip1, and Tubgcp5) in between BP1 and BP2 (Chai et al.
2003), which appear to result in developmental behavioral
problems when disturbed (Doornbos et al. 2009; Tam et al.
2010; van der Zwaag et al. 2010; von der Lippe et al. 2011).
Cyfip1 (cytoplasmic FMRP interacting protein, also known
as Sra-1) is an intriguing candidate among them because it
binds with the Fragile X protein (Schenck et al. 2001).
Microarray analysis using lymphoblastoid cells from males
with autism due to a 15q11–q13 duplication reveal that
Cyfip1 is upregulated (Nishimura et al. 2007). Although
there is no mouse model of Cyfip1 at this moment, it would
be interesting to make both Cyfip1 deletion and transgene
animals since individuals with 15q duplications and AS
deletion patients have a larger deletion that includes Cyfip1
(Sahoo et al. 2006).
Genomic diseases in human chromosome 15q11–q13
In humans, a paternal deletion of 15q11–q13 causes PWS in
which the patient shows hypotonia, obesity, cognitive deficit,
and behavioral problems, including obsessive-compulsive
disorder (Cassidy and Driscoll 2009; Chamberlain and
Lalande 2010b). Maternal deletion of this region causes
AS, which includes motor dysfunction, frequent seizures,
learning disability, absent speech, and characteristic happy
demeanor (Van Buggenhout and Fryns 2009). Both PWS and
AS share ASD features (Schanen 2006; Sutcliffe and Nurmi
2003). On the other hand, duplication of this region is known
to be the most frequent cytogenetic abnormality in ASDs
(Hogart et al. 2010; Vorstman et al. 2006). Autism with 15q
duplication syndrome was first reported as partial trisomy of
chromosome 15 (Gillberg et al. 1991). It is widely believed
that maternally duplicated cases cause autism, but paternally
duplicated ones do not (Bolton et al. 2001; Browne et al.
1997; Cook et al. 1997; Mao et al. 2000; Repetto et al. 1998;
Roberts et al. 2002). On the other hand, cases with
developmental delay are documented with paternal duplica-
tions (Bolton et al. 2004; Mao et al. 2000; Mohandas et al.
1999; Roberts et al. 2002; Veltman et al. 2005). A recent
screening using multiplex ligation-dependent probe amplifi-
cation (MLPA) did not detect maternal duplication, suggesting
that ASD cases in maternal duplication are not as frequent as
previously assumed (Depienne et al. 2009). Recent advances
in genetic analyses, such as array CGH, and their clinical
application are expected to detect larger numbers of clinical
cases for 15q duplication.
A mouse model for 15q duplication
Using a chromosome-engineering technique (Mills and
Bradley 2001; van der Weyden and Bradley 2006; Yu and
Bradley 2001), a model for human chromosome 15q
duplication has been generated (Nakatani et al. 2009). The
duplication was confirmed in ES cells by Southern blotting
and in mice by fluorescence in situ hybridization (FISH)
and CGH arrays. Southern blot analysis using methylation
sensitive and insensitive restriction enzymes, and a probe
near the IC, indicated that allele-specific methylation is
conserved in mice with the duplication. As the region is
imprinted, the duplication is classified into two types:
patDp/+ mice, in which the duplicated region is derived
from the paternal allele; and matDp/+ mice, in which the
duplication is derived from the maternal allele.
Both patDp/+ and matDp/+ mice breed normally and are
fertile (Nakatani et al. 2009). The patDp/+ male mice begin
to show an increase in body weight after 15 weeks and the
body weight of patDp/+ mice is significantly greater than
that of the WTafter 20 weeks. The fact that both decreased
(PWS) and increased (15q duplication) gene expressions of
PWS regions lead to obesity is contradictory, but rather
intriguing. As described above, Atp10a seems to be
involved in metabolism and body weight (Dhar et al.
2004). Further, some of forebrain specific KO mice of
Gabrb3 also become obese (Ferguson et al. 2007). The
PWS region is involved in aspects of metabolism and above
a certain critical threshold, the amounts of the genes and
their products, regardless of any increase or decrease, may
result in an abnormal pathway of metabolism.
Histological analyses, either at the macroscopic level or
at the microscopic level, using simple staining such as
hematoxylin–eosin or Bodian staining, detect no significant
difference between mice with the duplication and WT mice
(Nakatani et al. 2009). Recent studies reveal that synaptic
adhesion molecules, and their associated proteins, are
known to be rare mutation cases in autism (Betancur et al.
2009; Bourgeron 2009; Toro et al. 2010). For example,
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Shank3 mutant mice display abnormality in spines (Bozdagi
et al. 2010; Peca et al. 2011). Thus, it will be quite interesting
as to whether spine or synaptic abnormality is observed in
15q duplication mice or other models.
Autistic-like behavior of 15q duplication mice
Behavioral analyses are essential for animal models of
autism because major phenotypes of ASDs are behavioral
abnormalities and the diagnosis is made by three major
phenotypes: impairment in social interaction, impaired
social communication, restricted interest and behavior, or
resistance to change. Mouse behavioral tests corresponding
to human autistic phenotypes have been reported (Moy and
Nadler 2008; Silverman et al. 2010). The systematic
behavioral analyses were performed for 15q duplication
mice (Nakatani et al. 2009). First, in the three-chamber test
for social interaction, WT mice display more time spent
near a novel mouse than an empty cage, while no difference
of time spent around the novel mouse and the empty cage is
observed in patDp/+ mice. In comparison with time
between an inanimate object and an empty cage, both
patDp/+ and WT mice spend more time near the object than
empty cage, indicating that patDp/+ mice are able to see the
object. Interestingly, WT mice spend more time around a
novel mouse compared with an inanimate object, whereas
there was no difference in time spent between the novel
mouse and the inanimate object in patDp/+ mice. On the
other hand, there was no significant difference between
matDp/+ and WT mice in the three-chamber test. These
results indicate that patDp/+ mice exhibit impaired social
interaction. Similarly, Gabrb3−/− mice spend less time in
the proximity of unfamiliar mice than do their control
counterparts in a similar social behavior test, although some
aspects of social curiosity appear to remain intact (DeLorey
et al. 2008).
Second, patDp/+, but not matDp/+, mice display
abnormal ultrasonic vocalizations (USVs) (Nakatani et al.
2009). When the pups are separated from their dams, they
produce USVs. In WT pups, the numbers of USVs reach a
peak around postnatal day five (P5) and then gradually
decrease until P14, when their eyes are open and they can
communicate through the visual pathway. In contrast, the
numbers of USVs remain high at P7 or even at P14 in
patDp/+ mice, suggesting that the developmental course of
USVs in patDp/+ mice is delayed compared with WT.
These results demonstrate that patDp/+ mice may be
developmentally abnormal in comparison with WT, al-
though the larger number of USVs in patDp/+ pups may
reflect higher anxiety and fear in response to isolation
stress. No difference of USVs between matDp/+ and WT
mice was observed. The increased USVs were also
observed in mice with a maternal deletion from Ube3a to
Gabrb3 (Jiang et al. 2010).
Third, ritualistic behavioral inflexibility seen in autistic
patients is examined by reversal tasks using learning mazes.
In the Barnes maze, WT, patDp/+, and matDp/+ mice
exhibit intact spatial learning and memory. In a reversal test,
in which the target is altered to the opposite position, WT
and matDp/+ mice learn the new target position, whereas
patDp/+ mice return to the original position more often than
WT and matDp/+ mice, indicating that patDp/+ mice
display resistance to change or perseveration (Nakatani et
al. 2009). patDp/+ mice also show similar behavior in the
Morris water maze. These results suggest that patDp/+ mice
exhibit behavioral inflexibility.
In addition to these phenotypes, patDp/+ mice display
novelty-induced anxiety and decreased exploratory activity
(Tamada et al. 2010). Interestingly, anxiety is also observed
in paternal duplication of 15q11–q13 in humans (Mao et al.
2000; Veltman et al. 2005). Mice with maternal deficiency
for just the Ube3a gene also show decreased exploratory
behavior (Allensworth et al. 2011). In several tests
involving food deprivation, such as the novelty suppressed
test, radial maze, and Y-maze, patDp/+ mice display
peculiar behavior (Tamada et al. 2010). Even though
patDp/+ mice must be hungry after food deprivation, they
do not rush to feed and take more time to proceed to feed
than WT mice, and finally perform some tasks that are
equivalent to the WT. This behavior is likely to reflect a
lack of desire. patDp/+ mice also show less marble burying
behavior (Tamada et al. 2010), a method commonly used to
assess obsessive-compulsive behavior, which is also seen in
Gabrb3 KO mice (Hashemi et al. 2007).
Abnormal serotonin in 15q duplication mice
The mouse model for 15q duplication can be considered an
artificial founder mouse to unravel which gene and/or
region in 15q11–q13 is critical for autistic phenotypes. A
series of bacterial artificial chromosome (BAC), yeast
artificial chromosome (YAC), or other engineered mice
with longer insertions that cover the duplicated region will
provide useful materials for further investigation. Alterna-
tively, genetic rescue experiments crossed with a series of
knockout or deficient mice will be required to identify the
gene.
The primary benefit of the mouse model is that it allows
us to study abnormality at the molecular and cellular levels.
Major behavioral phenotypes appear in patDp/+ mice but
not in matDp/+ mice (Nakatani et al. 2009); therefore,
genes in the maternally imprinted region can be regarded as
candidates for abnormal behaviors observed in patDp/+
mice. Among them, MBII-52, a mouse brain specific
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snoRNA 52 in a huge cluster of non-coding RNAs, would
be an interesting candidate for the following reasons. First,
MBII-52 is a paternally expressed gene. Second, HBII-52, a
human homolog of MBII-52, is reported to be involved in
posttranscriptional modification of the serotonin 2c receptor
(5-HT2cR) (Kishore and Stamm 2006). Third, serotonin
(5-HT) is well known to be related to the pathophysiology
of autistic phenotypes (Whitaker-Azmitia 2005). Fourth,
5-HT2cR is the only G-protein coupled receptor that under-
goes A to I RNA editing, resulting in an amino acid
substitution in the second loop of the cytoplasmic domains
(Seeburg 2002), which may affect G-protein coupling
efficiency. MBII-52 RNA displays an approximately two-
fold increase in expression in the patDp/+ mice brain
compared with matDp/+ and WT mice (Nakatani et al.
2009). Pyrosequencing analyses revealed that the RNA
editing ratio in potential editing sites of 5-HT2cR in patDp/+
mice was higher than that in matDp/+ or WT mice. This
suggests that increased snoRNA in the patDp/+ brains may
affect the RNA editing of 5-HT2cR. Furthermore, a specific
agonist for 5-HT2cR induces higher intracellular Ca2+
concentration in primary cultured neurons derived from
patDp/+ mice compared with matDp/+ and WT neurons,
indicating that serotonergic signals in patDp/+ neurons are
different from matDp/+ and WT neurons. This result
suggests that alterations in RNA editing of 5-HT2cR may
affect serotonergic signals in neurons and that this alteration
in serotonergic signals in patDp/+ neurons may recapitulate
abnormal behavior in patDp/+ mice.
Neurochemical analyses revealed abnormal levels of 5-
HTand its metabolites in the adult cerebellum and midbrain
of the duplication mouse. Interestingly, 5-HT in patDp/+
mice was also observed to decrease in all brain regions
tested during postnatal weeks 1–3 (Tamada et al. 2010).
These results suggest that abnormal 5-HT levels during
developmental stages affect development of neurons and
neural circuits, and may recapitulate the abnormal behavior
seen in patDp/+ mice. Interestingly, the mean 5-HT
concentrations are larger in Ndn KO mice than in WT,
and the morphologies of 5-HT fibers are altered (Zanella et
al. 2008). Combined with these findings, Ndn in the region
may be involved in the metabolism and development of 5-
HT. Ndn facilitates TrkA signaling for sensory neuron
survival (Kuwako et al. 2005). The molecular mechanisms
by which Ndn might affect 5-HT metabolism and develop-
ment remain unknown.
Phenotypes (in)dependent on copy variants
Mice with a 15q duplication and other genetically engineered
mice for genes in 15q11–q13 share some phenotypes, such as
obesity, social behavior, and 5-HT concentration. Serotonin
concentration seems to correlate with gene dosage of Ndn
(Tamada et al. 2010; Zanella et al. 2008); however, complex
phenotypes such as metabolism, weight control, or social
behavior are unlikely to be dependent on simple gene dosage
or copy number variants, but above a certain critical
threshold, increases or decrease of gene expression may
produce the abnormal pathway of these phenotypes.
The idea that phenotypes are dependent on copy variants
may not be correct and their underlying mechanisms are
unlikely to be simple in humans. In contrast to the
interstitial duplication of human chromosome 15q, termed
idic (15) syndrome individuals, the presence of a supernu-
merary marker chromosome formed by the inverted
duplication of proximal chromosome 15, resulting in partial
tetrasomy 15q, often display increased, yet inappropriate,
social behaviors (Battaglia et al. 2010).
A gap between the mouse model and the human patient
The mouse model for 15q duplication as an animal model for
human neuropsychiatric disease fulfills construct validity, in
which it possesses the same chromosomal abnormality as
human patients. Thus, the model can be regarded as a
humanoid mouse model for autism in one aspect (Takumi
2010). In terms of humanized models, Tabuchi et al. report a
KI mouse for an NLGN3 R541C mutant (Tabuchi et al.
2007). However, the same KI mouse independently generated
by Dr. Heintz’s group displays no significant or mild social
abnormality (Chadman et al. 2008). Further humanized
model mice with rare mutations of other molecules, such as
serotonin transporter G56A KI mice (Veenstra-Vanderweele
et al. 2009), will be expected to display the phenotypes seen
in humans.
The allele-specific phenotypes that appeared in 15q
model mice will imply some biological significance that
can provide a general concept. However, it is surprising that
patDp/+ mice, but not matDp/+ mice, display abnormal
social behavior (Nakatani et al. 2009) because maternally
duplicated cases in humans are likely to result in an ASD
phenotype, while paternal duplications do not (Cook et al.
1997). Although allele-specific methylation seems to be
conserved, at least around the IC, in mice with a duplication,
the possibility that the imprinting status in other regions is
different between human and mouse is not excluded. The
timing and mechanism of the expression of the downstream
non-coding Snurf-Snrpn exons seem to be different between
human and mouse (Chamberlain et al. 2010). Recent
systematic analyses of the mouse epigenome reveal that
Ube3a and a GABA receptor subunit are differentially
imprinted in different brain areas (Gregg et al. 2010).
Alternatively, epigenetic status other than DNA methylation
may be different in mice from that in humans. Quantitative
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analysis of GABRB3 transcripts in PWS and AS brain
samples show evidence for a paternal expression bias when a
biparental 15q11–q13 contribution is lacking (Hogart et al.
2007). The Ube3a-ATS is thought to regulate expression by
turning off Ube3a on the paternal allele. This may cause
difference between maternal and paternal duplication animals
as well and should be investigated. At the very least, there is
a significant variability and diversity of clinical phenotypes
and gene expression in human chromosome 15q11–q13
duplication syndrome (Hogart et al. 2009; Piard et al. 2010).
Further detailed epigenetic analyses both in humans and
mice will provide an insight into the imprinting mechanisms.
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